Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term overexpression. Found 28 abstracts

no pagination
Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH. Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunology Immunotherapy. 2012 May;61(5):629-41.
Leonard JP, LaCasce AS, Smith MR, Noy A, Chirieac LR, Rodig SJ, Yu JQ, Vallabhajosula S, Schoder H, English P, Neuberg DS, Martin P, Millenson MM, Ely SA, Courtney R, Shaik N, Wilner KD, Randolph S, Van den Abbeele AD, Chen-Kiang SY, Yap JT, Shapiro GI. Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood. 2012 May;119(20):4597-607.   PMCID: not NIH funded
Matulonis UA, Sharma S, Ghamande S, Gordon MS, Del Prete SA, Ray-Coquard I, Kutarska E, Liu H, Fingert H, Zhou XF, Danaee H, Schilder RJ. Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. Gynecologic Oncology. 2012 Oct;127(1):63-9.   PMCID: Not NIH Funded
Rizzolio F, Lucchetti C, Caligiuri I, Marchesi I, Caputo M, Klein-Szanto A, Bagella L, Castronovo M, Giordano A. Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Cell death and differentiation. 2012 Jul;19(7):1152-61.   PMCID: PMC3374078
Dees EC, Infante JR, Cohen RB, O'Neil BH, Jones S, von Mehren M, Danaee H, Lee Y, Ecsedy J, Manfredi M, Galvin K, Stringer B, Liu H, Eton O, Fingert H, Burris H. Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 2011 Apr;67(4):945-54.   PMCID: PMC3026871
Ohashi S, Natsuizaka M, Wong GS, Michaylira CZ, Grugan KD, Stairs DB, Kalabis J, Vega ME, Kalman RA, Nakagawa M, Klein-Szanto AJ, Herlyn M, Diehl JA, Rustgi AK, Nakagawa H. Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors. Cancer Research. 2010 May;70(10):4174-84.   PMCID: PMC3007622
Cohen RB, Jones SF, Aggarwal C, von Mehren M, Cheng J, Spigel DR, Greco FA, Mariani M, Rocchetti M, Ceruti R, Comis S, Laffranchi B, Moll J, Burris HA. A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors. Clinical Cancer Research. 2009 Nov;15(21):6694-701.
Steffen AC, Orlova A, Wikman M, Nilsson FY, Stahl S, Adams GP, Tolmachev V, Carlsson J. Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2006 Jun;33(6):631-8.
Tang BQ, Kadariya Y, Murphy ME, Kruger WD. The methionine salvage pathway compound 4-methylthio-2oxobutanate causes apoptosis independent of down-regulation of ornithine decarboxylase. Biochemical pharmacology. 2006 Sep;72(7):806-15.
Zschemisch NH, Liedtke C, Dierssen U, Nevzorova YA, Wustefeld T, Borlak J, Manns MP, Trautwein C. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo. Hepatology (Baltimore, Md). 2006 Jul;44(1):164-73.
Siegelmann-Danieli N, Ben-Izhack O, Hanlon A, Ridge JA, Stein ME, Khandelwal V, Langer CJ. P53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure. Tumori. 2005 Jul;91(4):346-50.
Al Moustafa AE, Foulkes WD, Wong A, Jallal H, Batist G, Yu QY, Herlyn M, Sicinski P, Alaoui-Jamali MA. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene. 2004 Jul;23(30):5252-6.
Balsara BR, Pei JM, Mitsuuchi Y, Page R, Klein-Szanto A, Wang H, Unger M, Testa JR. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis. 2004 Nov;25(11):2053-9.
Finegan MM, Han AC, Edelson MI, Rosenblum NG. p16 expression in squamous lesions of the female genital tract. Journal of Molecular Histology. 2004 Feb;35(2):111-4.
Rowinsky EK, Schwartz GH, Gollob JA, Thompson JA, Vogelzang NJ, Figlin R, Bukowski R, Haas N, Lockbaum P, Li YP, Arends R, Foon KA, Schwab G, Dutcher J. Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer. Journal of Clinical Oncology. 2004 Aug;22(15):3003-15.
Mercapide J, Zhang SY, Fan X, Furio-Bacete V, Schneider J, de la Osa IL, Patchefsky AS, Klein-Szanto AJ, Castresana JS. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast. Molecular Carcinogenesis. 2002 Sep;35(1):6-12.
Sauter ER, Yeo UC, von Stemm A, Zhu WZ, Litwin S, Tichansky DS, Pistritto G, Nesbit M, Pinkel D, Herlyn M, Bastian BC. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Research. 2002 Jun;62(11):3200-6.
Liu SC, Hu Y, Sauter ER, Clapper ML, Chen SY, Lanfranchi HE, Engstrom PF, Klein-Szanto AJ. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa. Analytical and Quantitative Cytology and Histology. 1999 Apr;21(2):166-73.
Zeng H, Bain LJ, Belinsky MG, Kruh GD. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Research. 1999 Dec;59(23):5964-7.
Dexter DW, Reddy RK, Geles KG, Bansal S, Myint MA, Rogakto A, Leighton JC, Goldstein LJ. Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma. Clinical Cancer Research. 1998 Jun;4(6):1533-42.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term overexpression

overexpression expression carcinoma gene cancer in-vitro gene amplification progression breast-cancer protein expression cancer-cells growth cancer cells a kinase squamous-cell carcinoma cyclin d1 mutations in-vivo proliferation chemotherapy growth-factor apoptosis messenger-rna small-molecule inhibitor gene family amino-acids penetration her-2 senescence gene-expression gene- induction Dendritic cell Ovarian cancer-Vaccine-Clinical trial-Consolidation therapy computer-assisted ERBB2 phase-ii therapies squamous-cell carcinomas prognosis repressors zeb1 akt transgenic mice bladder-cancer tumorigenesis multidrug-resistance cdna cloning resistance-associated protein oropharynx immunotherapy cervical-cancer family peptide drug-efflux profile pathogenesis cell-cycle arrest methylthioadenosine phosphorylase mtap tumor-associated antigen immune-response invasive lobular carcinoma deprivation-induced apoptosis aurora kinase inhibitor ovarian-cancer chromosome 11q13 amplification retinoic acid emt cancer patients methionine transporter oncogene pegylated liposomal doxorubicin p-glycoprotein PTEN aneuploidy dependent kinase inhibitor p16(ink4a) human head Aurora A kinase MLN8054-Dose-limiting toxicity-Pharmacokinetics-Pharmacodynamics lymphocytes uterine cervix tgf-beta human-papillomavirus infection lines phase-ii trial centrosome amplification potent amplification pp2a cell HER-2 affibody-imaging-SKOV-3-tumour neck epithelial-cells oral mucosa cell lung-cancer rats tissues P53 immunohistochemistry-smoking-squamous cell carcinoma-tongue breast cancer binding upper aerodigestive tract genetics neu neck-cancer pten p53 in-situ mir-200 family advanced head growth-factor receptor survival tumors localization tumor response regulatory t-cells tumor invasion localization signal 1995 boer cj-oncogene-v10-p1833 Pin1 pRb phosphorylation-CDK-cell cycle control centrocytic lymphoma acceleration polyamines methylthioadenosine mmac1 proteins cyclin D1 regulators prolyl-isomerase pin1 protein-kinase b markers signaling pathway factor scatter factor protein human tissues tumor-suppressor keratinocytes leukotriene c-4 cellular retention antibody neoplasia Pharmacology & Pharmacy CCND1 myeloid-leukemia inhibition spitz nevi cancers hepatocellular-carcinoma immunochemistry image analysis tyrosine kinase inhibitor malignant-melanoma
Last updated on Wednesday, February 05, 2020